These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9334923)

  • 1. Differentiation of core gene products of the hepatitis B virus in infected liver tissue using monoclonal antibodies.
    Naoumov NV; Antonov KA; Miska S; Bichko V; Williams R; Will H
    J Med Virol; 1997 Oct; 53(2):127-38. PubMed ID: 9334923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity.
    Günther S; Paulij W; Meisel H; Will H
    Virology; 1998 Apr; 244(1):146-60. PubMed ID: 9581787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential distribution of hepatitis B core and E antigens in hepatocytes: analysis by monoclonal antibodies.
    Mondelli M; Tedder RS; Ferns B; Pontisso P; Realdi G; Alberti A
    Hepatology; 1986; 6(2):199-204. PubMed ID: 3514406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes.
    Hosono S; Tai PC; Wang W; Ambrose M; Hwang DG; Yuan TT; Peng BH; Yang CS; Lee CS; Shih C
    Virology; 1995 Sep; 212(1):151-62. PubMed ID: 7545853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The secretory core protein of human hepatitis B virus is expressed on the cell surface.
    Schlicht HJ; Schaller H
    J Virol; 1989 Dec; 63(12):5399-404. PubMed ID: 2685356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic, immunohistochemical, and ultrastructural studies of the production of hepatitis B virus in vitro.
    Gerber MA; Sells MA; Chen ML; Thung SN; Tabibzadeh SS; Hood A; Acs G
    Lab Invest; 1988 Aug; 59(2):173-80. PubMed ID: 2841537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus.
    Hadziyannis SJ; Lieberman HM; Karvountzis GG; Shafritz DA
    Hepatology; 1983; 3(5):656-62. PubMed ID: 6618432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in pre-core and basic core promoter regions of hepatitis B virus in chronic hepatitis B patients.
    Wang XL; Ren JP; Wang XQ; Wang XH; Yang SF; Xiong Y
    World J Gastroenterol; 2016 Mar; 22(11):3268-74. PubMed ID: 27004005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
    Schödel F; Peterson D; Milich D
    Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss.
    Ferns RB; Naoumov NV; Gilson RJ; Tedder RS
    J Clin Virol; 2007 Jul; 39(3):199-204. PubMed ID: 17526429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion.
    Kamijo N; Matsumoto A; Umemura T; Shibata S; Ichikawa Y; Kimura T; Komatsu M; Tanaka E
    World J Gastroenterol; 2015 Jan; 21(2):541-8. PubMed ID: 25593470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in hepatitis B virus core regions correlate with hepatocellular injury in Chinese patients with chronic hepatitis B.
    Tanaka H; Ueda H; Hamagami H; Yukawa S; Ichinose M; Miyano M; Mimura K; Nishide I; Zhang BX; Wang SW; Zhou SO; Li BH
    World J Gastroenterol; 2005 Aug; 11(30):4693-6. PubMed ID: 16094712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].
    Kim HJ; Yoo BC
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):149-56. PubMed ID: 12499800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the intrahepatic expression of 'e' and 'c' epitopes of the nucleocapsid protein of hepatitis B virus and viraemia.
    Ballaré M; Lavarini C; Brunetto MR; Petruzzelli E; Dovis M; Molino G; Bonino F
    Clin Exp Immunol; 1989 Jan; 75(1):64-9. PubMed ID: 2467769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea.
    Yoo BC; Park JW; Kim HJ; Lee DH; Cha YJ; Park SM
    J Hepatol; 2003 Jan; 38(1):98-103. PubMed ID: 12480566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B E antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection.
    Villari D; Pollicino T; Spinella S; Russo F; Campo S; Rodino G; Squadrito G; Longo G; Raimondo G
    Am J Clin Pathol; 1995 Feb; 103(2):136-40. PubMed ID: 7856554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan.
    Chen CH; Lee CM; Lu SN; Changchien CS; Eng HL; Huang CM; Wang JH; Hung CH; Hu TH
    J Clin Microbiol; 2005 Dec; 43(12):6000-6. PubMed ID: 16333089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus core promoter mutations in children with multiple anti-HBe/HBeAg reactivations result in enhanced promoter activity.
    Gerner P; Lausch E; Friedt M; Tratzmüller R; Spangenberg C; Wirth S
    J Med Virol; 1999 Dec; 59(4):415-23. PubMed ID: 10534721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha-2a and adefovir.
    Takkenberg B; Terpstra V; Zaaijer H; Weegink C; Dijkgraaf M; Jansen P; Beld M; Reesink H
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1527-35. PubMed ID: 21557773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
    Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
    J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.